{"gene":"ADAMTS20","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2003,"finding":"ADAMTS-20 is a secreted metalloprotease belonging to a distinct subfamily (GON-ADAMTSs) defined by 14-15 TSRs and a unique C-terminal GON domain, orthologous to C. elegans GON-1; recombinant ADAMTS-20 hydrolyzes a synthetic MMP substrate peptide, confirming catalytic activity.","method":"cDNA cloning, domain architecture analysis, Western blot, in vitro enzymatic assay with synthetic peptide substrate","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — cloning and biochemical characterization in a single lab; in vitro activity confirmed","pmids":["12562771"],"is_preprint":false},{"year":2003,"finding":"ADAMTS-9 (the closest paralog of ADAMTS-20) cleaves versican at the Glu441-Ala442 bond and aggrecan at Glu1771-Ala1772; the ancillary domains (including TSRs) are required for cell-surface localization and versicanase/aggrecanase activity, whereas the catalytic domain alone is insufficient. By close structural homology and shared subfamily membership, ADAMTS-20 is predicted to have similar substrate specificity.","method":"Transient transfection of COS-1 cells, Western blot of ECM substrates, site-directed mutagenesis, pulse-chase analysis, amino acid sequencing","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including mutagenesis, sequencing, and cell-based cleavage assay; directly demonstrated for ADAMTS-9 as the closest ADAMTS-20 paralog in the same subfamily paper","pmids":["12514189"],"is_preprint":false},{"year":2008,"finding":"ADAMTS20 is required for melanoblast survival in mouse skin; loss of Adamts20 (belted mice) causes a ~7-fold increase in melanoblast apoptosis specifically in the trunk at E13.5. ADAMTS20 is needed for melanoblasts to respond to soluble Kit ligand, and genetic interactions with Kit and KitL confirm functional overlap in Kit signaling. ADAMTS20 cleaves versican in vitro and is required for versican processing in vivo in skin.","method":"Dct-LacZ melanoblast fate tracking, TUNEL apoptosis assay, skin explant cultures, genetic compound-mutant analysis (bt/bt;Kit and bt/bt;Kitl), in vitro versican cleavage assay, in vivo versican immunostaining","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including in vitro cleavage, genetic epistasis, and cellular phenotype with functional readout; replicated across complementary assays","pmids":["18454205"],"is_preprint":false},{"year":2019,"finding":"ADAMTS20 function depends on B3GLCT-mediated O-glucosylation of its thrombospondin type-1 repeats (TSRs); loss of B3GLCT selectively abolishes ADAMTS20 function (causing white spotting and cleft palate phenotypes) while only partially reducing ADAMTS9 function, demonstrating that proper TSR glycosylation is required for ADAMTS20 activity in vivo.","method":"Mouse B3glct knockout models, genetic rescue experiments, biochemical analysis of ADAMTS20 secretion/processing, phenotypic comparison","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — genetic and biochemical evidence in mouse models with strong phenotypic concordance across two knockout alleles","pmids":["31600785"],"is_preprint":false},{"year":2023,"finding":"ADAMTS9 and ADAMTS20 together shed the ectodomain of MT1-MMP (membrane type 1-matrix metalloproteinase) by cleaving at the Tyr314-Gly315 bond in the MT1-MMP hinge region (between catalytic and hemopexin domains) and at a second site in the hemopexin domain; this cleavage depends on hinge O-glycosylation. Loss of ADAMTS9/20 increases MT1-MMP retention at the cell surface, elevating pro-MMP2 activation. MT1-MMP shedding does not underlie ADAMTS9/20's role in ciliogenesis.","method":"Quantitative terminomics (TAILS), clonal gene-edited RPE-1 cells (ADAMTS9 KO / ADAMTS20-null), reexpression rescue, Western blot for MT1-MMP catalytic domain fragment, pro-MMP2 activation assay, MT1-MMP knockdown epistasis","journal":"Molecular & cellular proteomics : MCP","confidence":"High","confidence_rationale":"Tier 1-2 — substrate identified by unbiased terminomics and validated orthogonally by fragment detection, reexpression, and epistasis experiments","pmids":["37169079"],"is_preprint":false}],"current_model":"ADAMTS20 is a secreted metalloprotease of the GON-ADAMTS subfamily that, through its ancillary TSR and GON domains, localizes to the extracellular matrix where it cleaves versican (required for melanoblast survival and Kit-ligand responsiveness in skin), sheds the MT1-MMP ectodomain to regulate cell-surface MMP activity, and whose function requires B3GLCT-mediated O-glucosylation of its TSRs."},"narrative":{"teleology":[{"year":2003,"claim":"Establishing that ADAMTS20 is a catalytically active secreted metalloprotease in a distinct GON-ADAMTS subfamily resolved the gene's basic enzymatic identity and domain organization, and the parallel demonstration that its closest paralog ADAMTS9 cleaves versican predicted a shared substrate specificity.","evidence":"cDNA cloning, domain analysis, in vitro peptide hydrolysis for ADAMTS20; COS-1 cell transfection, mutagenesis, and amino acid sequencing for ADAMTS9 versicanase activity","pmids":["12562771","12514189"],"confidence":"High","gaps":["Direct demonstration of versican cleavage by ADAMTS20 itself was not yet shown","No physiological substrate identified for ADAMTS20 in vivo","Synthetic peptide assay does not establish physiological relevance of catalytic activity"]},{"year":2008,"claim":"Demonstrating that ADAMTS20 cleaves versican both in vitro and in vivo, and that this activity is required for melanoblast survival and Kit-ligand responsiveness, established the first physiological role for ADAMTS20 and linked ECM remodeling to melanocyte biology.","evidence":"Dct-LacZ melanoblast tracking, TUNEL assays, skin explant cultures, in vitro versican cleavage, in vivo versican immunostaining, and genetic compound-mutant analysis with Kit/KitL in belted mice","pmids":["18454205"],"confidence":"High","gaps":["Mechanism by which versican cleavage promotes Kit signaling was not defined","Whether ADAMTS20 has additional ECM substrates beyond versican remained unknown","Role of ADAMTS20 in tissues other than skin was not addressed"]},{"year":2019,"claim":"Showing that B3GLCT-mediated O-glucosylation of TSRs is required for ADAMTS20 function — more so than for ADAMTS9 — established a post-translational regulatory mechanism that differentially controls paralog activity in vivo.","evidence":"Mouse B3glct knockout models, genetic rescue experiments, biochemical analysis of ADAMTS20 secretion and processing, phenotypic comparison (white spotting, cleft palate)","pmids":["31600785"],"confidence":"High","gaps":["Whether O-glucosylation affects ADAMTS20 secretion, folding, or substrate engagement was not resolved","Structural basis for the selective dependence of ADAMTS20 versus ADAMTS9 on B3GLCT was not determined"]},{"year":2023,"claim":"Identification of MT1-MMP as an ADAMTS9/20 substrate by unbiased terminomics, with cleavage at a specific hinge-region bond dependent on O-glycosylation, expanded ADAMTS20's substrate repertoire to include regulation of cell-surface metalloproteinase activity and downstream pro-MMP2 activation.","evidence":"TAILS terminomics in clonal ADAMTS9 KO / ADAMTS20-null RPE-1 cells, reexpression rescue, Western blot fragment detection, pro-MMP2 activation assay, MT1-MMP knockdown epistasis","pmids":["37169079"],"confidence":"High","gaps":["Relative contributions of ADAMTS9 versus ADAMTS20 to MT1-MMP shedding in vivo remain undefined","Whether MT1-MMP shedding underlies any ADAMTS20-dependent developmental phenotype (e.g., melanoblast survival) is untested","Full in vivo substrate repertoire of ADAMTS20 beyond versican and MT1-MMP is unknown"]},{"year":null,"claim":"The complete in vivo substrate repertoire of ADAMTS20, the structural basis for its selective dependence on TSR O-glucosylation, and the mechanism linking versican cleavage to Kit signaling remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of ADAMTS20 or its substrate complexes exists","Mechanistic link between versican processing and Kit-ligand signaling pathway has not been defined","Roles of ADAMTS20 in non-melanocyte lineages and non-skin tissues are poorly characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,4]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,2,4]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[1,2,4]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2]}],"complexes":[],"partners":["ADAMTS9","MMP14","VCAN","B3GLCT"],"other_free_text":[]},"mechanistic_narrative":"ADAMTS20 is a secreted metalloprotease of the GON-ADAMTS subfamily characterized by 14–15 thrombospondin type-1 repeats (TSRs) and a unique C-terminal GON domain; it cleaves versican in the extracellular matrix and sheds the MT1-MMP ectodomain to regulate cell-surface MMP activity [PMID:12562771, PMID:18454205, PMID:37169079]. In mouse skin, ADAMTS20-dependent versican processing is required for melanoblast survival and responsiveness to soluble Kit ligand, and loss of Adamts20 causes a dramatic increase in melanoblast apoptosis and white spotting [PMID:18454205]. ADAMTS20 activity depends on B3GLCT-mediated O-glucosylation of its TSRs; loss of this modification selectively abolishes ADAMTS20 function in vivo, producing white spotting and cleft palate [PMID:31600785]."},"prefetch_data":{"uniprot":{"accession":"P59510","full_name":"A disintegrin and metalloproteinase with thrombospondin motifs 20","aliases":[],"length_aa":1910,"mass_kda":214.7,"function":"May play a role in tissue-remodeling process occurring in both normal and pathological conditions. May have a protease-independent function in the transport from the endoplasmic reticulum to the Golgi apparatus of secretory cargos, mediated by the GON domain","subcellular_location":"Secreted, extracellular space, extracellular matrix","url":"https://www.uniprot.org/uniprotkb/P59510/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADAMTS20","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ADAMTS20","total_profiled":1310},"omim":[{"mim_id":"611681","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 20; ADAMTS20","url":"https://www.omim.org/entry/611681"},{"mim_id":"605421","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9; ADAMTS9","url":"https://www.omim.org/entry/605421"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Primary cilium","reliability":"Approved"},{"location":"Microtubules","reliability":"Additional"},{"location":"Mitotic spindle","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ADAMTS20"},"hgnc":{"alias_symbol":["GON-1"],"prev_symbol":[]},"alphafold":{"accession":"P59510","domains":[{"cath_id":"-","chopping":"29-54_77-111_130-188","consensus_level":"high","plddt":71.1176,"start":29,"end":188},{"cath_id":"3.40.390.10","chopping":"256-466","consensus_level":"medium","plddt":83.6898,"start":256,"end":466},{"cath_id":"3.40.1620.60","chopping":"480-552","consensus_level":"medium","plddt":75.2208,"start":480,"end":552},{"cath_id":"2.60.120.830","chopping":"721-841","consensus_level":"high","plddt":81.5444,"start":721,"end":841},{"cath_id":"-","chopping":"850-948","consensus_level":"medium","plddt":74.6398,"start":850,"end":948},{"cath_id":"2.20.100","chopping":"1081-1133","consensus_level":"medium","plddt":70.7179,"start":1081,"end":1133},{"cath_id":"2.30.30","chopping":"616-675","consensus_level":"medium","plddt":77.9953,"start":616,"end":675}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P59510","model_url":"https://alphafold.ebi.ac.uk/files/AF-P59510-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P59510-F1-predicted_aligned_error_v6.png","plddt_mean":69.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADAMTS20","jax_strain_url":"https://www.jax.org/strain/search?query=ADAMTS20"},"sequence":{"accession":"P59510","fasta_url":"https://rest.uniprot.org/uniprotkb/P59510.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P59510/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P59510"}},"corpus_meta":[{"pmid":"12514189","id":"PMC_12514189","title":"Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12514189","citation_count":272,"is_preprint":false},{"pmid":"10588887","id":"PMC_10588887","title":"The gon-1 gene is required for gonadal morphogenesis in Caenorhabditis elegans.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10588887","citation_count":147,"is_preprint":false},{"pmid":"18454205","id":"PMC_18454205","title":"The secreted metalloprotease ADAMTS20 is required for melanoblast survival.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18454205","citation_count":91,"is_preprint":false},{"pmid":"25798845","id":"PMC_25798845","title":"Genome-wide association studies in dogs and humans identify ADAMTS20 as a risk variant for cleft lip and palate.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25798845","citation_count":84,"is_preprint":false},{"pmid":"12562771","id":"PMC_12562771","title":"Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12562771","citation_count":69,"is_preprint":false},{"pmid":"15556862","id":"PMC_15556862","title":"GON-1 and fibulin have antagonistic roles in control of organ shape.","date":"2004","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15556862","citation_count":50,"is_preprint":false},{"pmid":"25080592","id":"PMC_25080592","title":"Perlecan antagonizes collagen IV and ADAMTS9/GON-1 in restricting the growth of presynaptic boutons.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25080592","citation_count":27,"is_preprint":false},{"pmid":"31600785","id":"PMC_31600785","title":"ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.","date":"2019","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31600785","citation_count":25,"is_preprint":false},{"pmid":"22419820","id":"PMC_22419820","title":"Identification of a novel ADAMTS9/GON-1 function for protein transport from the ER to the Golgi.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22419820","citation_count":22,"is_preprint":false},{"pmid":"37169079","id":"PMC_37169079","title":"Degradomic Identification of Membrane Type 1-Matrix Metalloproteinase as an ADAMTS9 and ADAMTS20 Substrate.","date":"2023","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/37169079","citation_count":11,"is_preprint":false},{"pmid":"26218657","id":"PMC_26218657","title":"Loss of C. elegans GON-1, an ADAMTS9 Homolog, Decreases Secretion Resulting in Altered Lifespan and Dauer Formation.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26218657","citation_count":8,"is_preprint":false},{"pmid":"32337892","id":"PMC_32337892","title":"Review of Potential Significance of Mutations of ADAMTS20, NF1 and PKHD1 Detected Using Next Generation Sequencing (NGS) in Dermal Fibrosarcoma Arising in Dermatofibrosarcoma Protuberans.","date":"2020","source":"Folia medica","url":"https://pubmed.ncbi.nlm.nih.gov/32337892","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7646,"output_tokens":1536,"usd":0.022989},"stage2":{"model":"claude-opus-4-6","input_tokens":4753,"output_tokens":1711,"usd":0.09981},"total_usd":0.122799,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"ADAMTS-20 is a secreted metalloprotease belonging to a distinct subfamily (GON-ADAMTSs) defined by 14-15 TSRs and a unique C-terminal GON domain, orthologous to C. elegans GON-1; recombinant ADAMTS-20 hydrolyzes a synthetic MMP substrate peptide, confirming catalytic activity.\",\n      \"method\": \"cDNA cloning, domain architecture analysis, Western blot, in vitro enzymatic assay with synthetic peptide substrate\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cloning and biochemical characterization in a single lab; in vitro activity confirmed\",\n      \"pmids\": [\"12562771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ADAMTS-9 (the closest paralog of ADAMTS-20) cleaves versican at the Glu441-Ala442 bond and aggrecan at Glu1771-Ala1772; the ancillary domains (including TSRs) are required for cell-surface localization and versicanase/aggrecanase activity, whereas the catalytic domain alone is insufficient. By close structural homology and shared subfamily membership, ADAMTS-20 is predicted to have similar substrate specificity.\",\n      \"method\": \"Transient transfection of COS-1 cells, Western blot of ECM substrates, site-directed mutagenesis, pulse-chase analysis, amino acid sequencing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including mutagenesis, sequencing, and cell-based cleavage assay; directly demonstrated for ADAMTS-9 as the closest ADAMTS-20 paralog in the same subfamily paper\",\n      \"pmids\": [\"12514189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ADAMTS20 is required for melanoblast survival in mouse skin; loss of Adamts20 (belted mice) causes a ~7-fold increase in melanoblast apoptosis specifically in the trunk at E13.5. ADAMTS20 is needed for melanoblasts to respond to soluble Kit ligand, and genetic interactions with Kit and KitL confirm functional overlap in Kit signaling. ADAMTS20 cleaves versican in vitro and is required for versican processing in vivo in skin.\",\n      \"method\": \"Dct-LacZ melanoblast fate tracking, TUNEL apoptosis assay, skin explant cultures, genetic compound-mutant analysis (bt/bt;Kit and bt/bt;Kitl), in vitro versican cleavage assay, in vivo versican immunostaining\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including in vitro cleavage, genetic epistasis, and cellular phenotype with functional readout; replicated across complementary assays\",\n      \"pmids\": [\"18454205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ADAMTS20 function depends on B3GLCT-mediated O-glucosylation of its thrombospondin type-1 repeats (TSRs); loss of B3GLCT selectively abolishes ADAMTS20 function (causing white spotting and cleft palate phenotypes) while only partially reducing ADAMTS9 function, demonstrating that proper TSR glycosylation is required for ADAMTS20 activity in vivo.\",\n      \"method\": \"Mouse B3glct knockout models, genetic rescue experiments, biochemical analysis of ADAMTS20 secretion/processing, phenotypic comparison\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and biochemical evidence in mouse models with strong phenotypic concordance across two knockout alleles\",\n      \"pmids\": [\"31600785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADAMTS9 and ADAMTS20 together shed the ectodomain of MT1-MMP (membrane type 1-matrix metalloproteinase) by cleaving at the Tyr314-Gly315 bond in the MT1-MMP hinge region (between catalytic and hemopexin domains) and at a second site in the hemopexin domain; this cleavage depends on hinge O-glycosylation. Loss of ADAMTS9/20 increases MT1-MMP retention at the cell surface, elevating pro-MMP2 activation. MT1-MMP shedding does not underlie ADAMTS9/20's role in ciliogenesis.\",\n      \"method\": \"Quantitative terminomics (TAILS), clonal gene-edited RPE-1 cells (ADAMTS9 KO / ADAMTS20-null), reexpression rescue, Western blot for MT1-MMP catalytic domain fragment, pro-MMP2 activation assay, MT1-MMP knockdown epistasis\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — substrate identified by unbiased terminomics and validated orthogonally by fragment detection, reexpression, and epistasis experiments\",\n      \"pmids\": [\"37169079\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADAMTS20 is a secreted metalloprotease of the GON-ADAMTS subfamily that, through its ancillary TSR and GON domains, localizes to the extracellular matrix where it cleaves versican (required for melanoblast survival and Kit-ligand responsiveness in skin), sheds the MT1-MMP ectodomain to regulate cell-surface MMP activity, and whose function requires B3GLCT-mediated O-glucosylation of its TSRs.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ADAMTS20 is a secreted metalloprotease of the GON-ADAMTS subfamily characterized by 14–15 thrombospondin type-1 repeats (TSRs) and a unique C-terminal GON domain; it cleaves versican in the extracellular matrix and sheds the MT1-MMP ectodomain to regulate cell-surface MMP activity [PMID:12562771, PMID:18454205, PMID:37169079]. In mouse skin, ADAMTS20-dependent versican processing is required for melanoblast survival and responsiveness to soluble Kit ligand, and loss of Adamts20 causes a dramatic increase in melanoblast apoptosis and white spotting [PMID:18454205]. ADAMTS20 activity depends on B3GLCT-mediated O-glucosylation of its TSRs; loss of this modification selectively abolishes ADAMTS20 function in vivo, producing white spotting and cleft palate [PMID:31600785].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that ADAMTS20 is a catalytically active secreted metalloprotease in a distinct GON-ADAMTS subfamily resolved the gene's basic enzymatic identity and domain organization, and the parallel demonstration that its closest paralog ADAMTS9 cleaves versican predicted a shared substrate specificity.\",\n      \"evidence\": \"cDNA cloning, domain analysis, in vitro peptide hydrolysis for ADAMTS20; COS-1 cell transfection, mutagenesis, and amino acid sequencing for ADAMTS9 versicanase activity\",\n      \"pmids\": [\"12562771\", \"12514189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct demonstration of versican cleavage by ADAMTS20 itself was not yet shown\",\n        \"No physiological substrate identified for ADAMTS20 in vivo\",\n        \"Synthetic peptide assay does not establish physiological relevance of catalytic activity\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that ADAMTS20 cleaves versican both in vitro and in vivo, and that this activity is required for melanoblast survival and Kit-ligand responsiveness, established the first physiological role for ADAMTS20 and linked ECM remodeling to melanocyte biology.\",\n      \"evidence\": \"Dct-LacZ melanoblast tracking, TUNEL assays, skin explant cultures, in vitro versican cleavage, in vivo versican immunostaining, and genetic compound-mutant analysis with Kit/KitL in belted mice\",\n      \"pmids\": [\"18454205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which versican cleavage promotes Kit signaling was not defined\",\n        \"Whether ADAMTS20 has additional ECM substrates beyond versican remained unknown\",\n        \"Role of ADAMTS20 in tissues other than skin was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing that B3GLCT-mediated O-glucosylation of TSRs is required for ADAMTS20 function — more so than for ADAMTS9 — established a post-translational regulatory mechanism that differentially controls paralog activity in vivo.\",\n      \"evidence\": \"Mouse B3glct knockout models, genetic rescue experiments, biochemical analysis of ADAMTS20 secretion and processing, phenotypic comparison (white spotting, cleft palate)\",\n      \"pmids\": [\"31600785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether O-glucosylation affects ADAMTS20 secretion, folding, or substrate engagement was not resolved\",\n        \"Structural basis for the selective dependence of ADAMTS20 versus ADAMTS9 on B3GLCT was not determined\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of MT1-MMP as an ADAMTS9/20 substrate by unbiased terminomics, with cleavage at a specific hinge-region bond dependent on O-glycosylation, expanded ADAMTS20's substrate repertoire to include regulation of cell-surface metalloproteinase activity and downstream pro-MMP2 activation.\",\n      \"evidence\": \"TAILS terminomics in clonal ADAMTS9 KO / ADAMTS20-null RPE-1 cells, reexpression rescue, Western blot fragment detection, pro-MMP2 activation assay, MT1-MMP knockdown epistasis\",\n      \"pmids\": [\"37169079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Relative contributions of ADAMTS9 versus ADAMTS20 to MT1-MMP shedding in vivo remain undefined\",\n        \"Whether MT1-MMP shedding underlies any ADAMTS20-dependent developmental phenotype (e.g., melanoblast survival) is untested\",\n        \"Full in vivo substrate repertoire of ADAMTS20 beyond versican and MT1-MMP is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The complete in vivo substrate repertoire of ADAMTS20, the structural basis for its selective dependence on TSR O-glucosylation, and the mechanism linking versican cleavage to Kit signaling remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model of ADAMTS20 or its substrate complexes exists\",\n        \"Mechanistic link between versican processing and Kit-ligand signaling pathway has not been defined\",\n        \"Roles of ADAMTS20 in non-melanocyte lineages and non-skin tissues are poorly characterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ADAMTS9\",\n      \"MMP14\",\n      \"VCAN\",\n      \"B3GLCT\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}